Karl Eugen Hauptmann

Author

Krankenhaus der Barmherzigen Brüder Trier

Also Known As

K HAUPTMANN, K. E. Hauptmann, K. Hauptmann, K.-E. Hauptmann, K.E. Hauptmann, Karl E. Hauptmann, Karl Eugen Hauptmann, Karl Hauptmann

Publications

4.3K

Citations

H-Index

Concepts

All Affiliations

Krankenhaus der Barmherzigen Brüder Trier Deutsches Herzzentrum der Charité Helios Hospital Siegburg Klinikum Ludwigshafen München Klinik Bogenhausen

About

Karl Eugen Hauptmann is an author at Krankenhaus der Barmherzigen Brüder Trier specializing in cardiovascular disease, medicine, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	20	1.4K
2	Public Health	9	9	914
3	Emergency Medicine	5	5	451
4	Health Sciences	2	2	70
5	Geriatrics	1	1	20

Karl Eugen Hauptmann

Publications

4.2K

Citations

H-Index

Page 1

	Year	Citations
Randomized Study to Assess the Effectiveness of Slow- and Moderate-Release Polymer-Based Paclitaxel-Eluting Stents for Coronary Artery Lesions Antonio Colombo, J Drzewiecki, Adrian Banning, Circulation	2003	1K
TAXUS I Eberhard Grube, Sigmund Silber, Karl Eugen Hauptmann, Circulation	2003	865
Initial Worldwide Experience With the WATCHMAN Left Atrial Appendage System for Stroke Prevention in Atrial Fibrillation Peter Sick, Gerhard Schüler, Karl Eugen Hauptmann, Journal of the American College of Cardiology ThrombosisElectrophysiological EvaluationDevice TherapyCardiovascular DiseaseIschemic Stroke	2007	353
Prospective Multicenter Evaluation of the Direct Flow Medical Transcatheter Aortic Valve Joachim Schöfer, Antonio Colombo, Silvio Klugmann, Journal of the American College of Cardiology Prospective Multicenter EvaluationCardiovascular DiseaseBlood Flow MeasurementVascular SurgeryValve Disease	2013	159
Comparison of the Effectiveness of Transcatheter Aortic Valve Implantation in Patients With Stenotic Bicuspid Versus Tricuspid Aortic Valves (from the German TAVI Registry) Timm Bauer, Axel Linke, Horst Sievert, The American Journal of Cardiology German Tavi RegistryEndovascular TechniqueCardiovascular DiseaseVascular SurgeryOutcomes Research	2013	149
Embolic protection devices for carotid artery stenting: better results than stenting without protection? R. Zahn, B. Màrk, N. Niedermaier, European Heart Journal	2004	112
A Multicenter Randomized Trial Comparing Amphilimus- With Paclitaxel-Eluting Stents in De Novo Native Coronary Artery Lesions Didier Carrié, Jacques Berland, Stefan Verheye, Journal of the American College of Cardiology Percutaneous Coronary InterventionCardiovascular DiseasePaclitaxel-eluting StentsPharmacologyClinical Trials	2012	110
Final 5-Year Results of the TAXUS II Trial Sigmund Silber, Antonio Colombo, Adrian Banning, Circulation	2009	109
Randomised comparison of Nobori, biolimus A9-eluting coronary stent with a Taxus(R), paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the Nobori 1 trial. Bernard Chevalier, Patrick W. Serruys, Sigmund Silber, PubMed	2007	107
Carotid artery stenting in octogenarians: results from the ALKK Carotid Artery Stent (CAS) Registry Ralf Zahn, Thomas Ischinger, Matthias Hochadel, European Heart Journal	2006	101

Page 1